A comprehensive evaluation of the costs (both personal and to the broader community) of illicit drug use in New Zealand, including legal drugs diverted to the illicit market and excluding alcohol and tobacco.

The Pacific 'drug highway' has spilled over into domestic markets for illicit drug consumption and production in the Pacific Islands region. This analysis identifies the key trends and dynamics driving the drug market in the Pacific and the implications for societies, traditional power structures and states.

In Australia, threshold quantities of illicit drugs act as an indicator of supply offences in distinguishing traffickers from users. This analysis maps out how current sentencing practices respond to offenders involved in ‘social supply’ and ‘minimally commercial supply’ who are charged with drug trafficking.

This report uses existing quantitative and qualitative data to better understand the segmentation of Australia’s heroin and methamphetamine markets and the markets’ transnational connections. The authors also examine the profits made by criminal actors at each level of Australia’s vertically integrated illicit drug supply chains.

Treating drug-related offenders is far more effective than sending them to prison, according to this research. The researchers compared re-offending rates among Drug Court participants with offenders who had been deemed eligible for the Drug Court but not placed on it. Offenders were followed up over an average period of 13.5 years.